SCHEMBL2422502

SCHEMBL2422502

CCCCCCCCCCCCCCC(CCC)OCC(C)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
GPR84 Q9NQS5 6/20 0.42
SPHK1 Q9NYA1 2/20 0.42
FFAR1 O14842 1/20 0.42
TDP1 Q9NUW8 1/20 0.40
ACE2 Q9BYF1 1/20 0.39
LMNA P02545 2/20 0.38
HSD17B10 Q99714 1/20 0.38
LCK P06239 1/20 0.37
PPARD Q03181 1/20 0.37
ZDHHC20 Q5W0Z9 1/20 0.37
ZDHHC2 Q9UIJ5 1/20 0.37
CYP2D6 P10635 2/20 0.36
GMNN O75496 1/20 0.36
POLB P06746 1/20 0.36
THPO P40225 1/20 0.36
MTOR P42345 1/20 0.36
BLM P54132 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6680035 1.00 MAPT (0.44) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL25004972 0.96 MAPT (0.47) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL10657309 0.96 MAPT (0.47) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL6680325 0.96 MAPT (0.47) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL11613930 0.94 MAPT (0.46) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL9296222 0.92 MAPT (0.43) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL4511080 0.89 MAPT (0.44) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL11420196 0.87 MAPT (0.41) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL8729385 0.87 HSD17B10 (0.45) MAPTGPR84SPHK1FFAR1TDP1
SCHEMBL8520740 0.86 MAPT (0.42) MAPTGPR84SPHK1FFAR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220202841-A1 DERMATOLOGICAL FORMULATIONS FOR TREATMENT OF DERMATITIS KUPETSKY ERINE A (US) 2022-06-30 US claimed
CN-114099357-A Hydroxytyrosol-containing polyol-in-oil nano emulsion, and preparation method and application thereof 江苏瑞霆生物科技有限公司 2022-03-01 CN claimed
US-10744112-B2 Composition comprising avermectin compounds without solvents and propenetrating agents of avermectin compounds Nestlé Skin Health S.A. (CH) 2020-08-18 US claimed
US-10744147-B2 Composition comprising avermectin compounds without solid fatty substances Nestlé Skin Health S.A. (CH) 2020-08-18 US claimed
US-10695315-B2 Composition comprising avermectin compounds without gelling agents Nestlé Skin Health S.A. (CH) 2020-06-30 US claimed
CN-104284970-A Emulsifier composition and the use thereof EVONIK DEGUSSA CHINA CO LTD 2015-01-14 CN claimed
EP-1882029-B1 STRUCTURED SURFACTANT COMPOSITIONS SOLVAY USA INC (US) 2014-05-07 EP claimed
WO-2013170419-A1 EMULSIFIER COMPOSITION AND THE USE THEREOF Evonik Degussa (China) Co., Ltd. (CN) 2013-11-21 WO claimed
CN-102784070-A Stable hydroquinone-containing polyol-in-oil composition and preparation method thereof EVONIK DEGUSSA SPECIAL CHEMICAL SHANGHAI CO LTD 2012-11-21 CN claimed
CN-101223267-B Structured surfactant compositions RHODIA 2011-04-13 CN claimed
EP-1347747-B1 METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS OF PHARMACEUTICAL AGENTS BAXTER INT (US) 2006-03-08 EP claimed
WO-2005017134-A2 ISOZYME OF AUTOCLAVABLE SUPEROXIDE DISMUTASE (SOD) DERIVED FROM CURCUMA LONGA L COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-02-24 WO claimed
CN-1531920-A Sin-care composition ���Ǿ� 2004-09-29 CN claimed
US-20040175403-A1 Skin moisturizing composition JOHNSON & JOHNSON CONSUMER COMPANIES, INC. 2004-09-09 US claimed
EP-1454622-A1 Skin moisturizing composition Johnson & Johnson Consumer Companies, Inc. (US) 2004-09-08 EP claimed
US-20030064494-A1 Novel isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD and use of the said SOD in cosmetic, food, and pharmaceutical compositions COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2003-04-03 US claimed
CN-1404819-A Skin-care composition changing colour when dry JOHNSON & JOHNSON CONSUMER (US) 2003-03-26 CN claimed
US-20030044366-A1 Skin care composition that changes color upon drying DOLE VICTORIA F (US) 2003-03-06 US claimed
EP-1283032-A1 Skin care composition that changes color upon drying JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2003-02-12 EP claimed
US-6485950-B1 Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-11-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040175403-A1 Skin moisturizing composition DEGS1, COL14A1, CUTA MAPT 3328/4885GPR84 510/4885SPHK1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.